טוען...
Induction Immunosuppressive Therapy in the Elderly Kidney Transplant Recipient in the United States
SUMMARY: BACKGROUND AND OBJECTIVES: The choice of induction agent in the elderly kidney transplant recipient is unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The risks of rejection at 1 year, functional graft loss, and death by induction agent (IL2 receptor antibodies [IL2RA], alemtuzu...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Nephrology
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3087785/ https://ncbi.nlm.nih.gov/pubmed/21511836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07540810 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|